Pancreatic Cancer Research

ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteNo recent work listed

Sharla Wells‐Di Gregorio

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5193-7448; OpenAlex author ID A5086662015. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2011: 1 trial · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 2

  1. Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study. Co-author DOI 10.4251/wjgo.v14.i6.1175↗
  2. Association of pre-existing mental illness with all-cause and cancer-specific mortality among Medicare beneficiaries with pancreatic cancer. Co-author DOI 10.1016/j.hpb.2020.08.002↗

Trials 1

  1. Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors Principal investigator NCT01929720↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jordan M. Cloyd · 2 shared papers, 2021–2022 · strength 0.28
  2. Timothy Michael Pawlik · 2 shared papers, 2021–2022 · strength 0.28
  3. Aslam M. Ejaz · 2 shared papers, 2021–2022 · strength 0.28
  4. Lena Stevens · 1 shared paper, 2022 · strength 0.16
  5. Zachary J. Brown · 1 shared paper, 2022 · strength 0.16
  6. Heena P. Santry · 1 shared paper, 2022 · strength 0.16
  7. Anghela Z. Paredes · 1 shared paper, 2021 · strength 0.12
  8. J. Madison Hyer · 1 shared paper, 2021 · strength 0.12
  9. Diamantis I. Tsilimigras · 1 shared paper, 2021 · strength 0.12
  10. Allan Tsung · 1 shared paper, 2021 · strength 0.12
  11. Mary E. Dillhoff · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.